Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group.
Kroiss R, Winkler V, Kalteis K, Bikas D, Rudas M, Tea M, Fuerhauser C, Muhr D, Cerny H, Glueck S, Petru E, Concin H, Kubista E, Oefner P, Wagner T; Austrian Hereditary Breast and Ovarian Cancer Group.
Kroiss R, et al. Among authors: glueck s.
J Cancer Res Clin Oncol. 2008 Oct;134(10):1113-21. doi: 10.1007/s00432-008-0383-5. Epub 2008 Apr 8.
J Cancer Res Clin Oncol. 2008.
PMID: 18392852